Zeaxanthin from Porphyridium purpureum induces apoptosis in human melanoma cells expressing the oncogenic BRAF V600E mutation and sensitizes them to the BRAF inhibitor vemurafenib

Abstract : Zeaxanthin, an abundant carotenoid present in fruits, vegetables and algae was reported to exert antiproliferative activity and induce apoptosis in human uveal melanoma cells. It also inhibited uveal melanoma tumor growth and cell migration in nude mice xenograft models. Here we report that zeaxanthin purified from the rhodophyte Porphyridium purpureum (Bory) K.M.Drew & R.Ross, Porphyridiaceae, promotes apoptosis in the A2058 human melanoma cell line expressing the oncogenic BRAF V600E mutation. Zeaxanthin 40 µM (IC 50) induced chromatin condensation, nuclear blebbing, hypodiploidy, accumulation of cells in sub-G1 phase, DNA internucleosomal fragmentation and activation of caspase-3. Western blot analysis revealed that zeaxanthin induced up-regulation of the pro-apoptotic factors Bim and Bid and inhibition of NF-B transactivation. Additionnally, zeaxanthin sensitized A2058 melanoma cells in vitro to the cytotoxic activity of vemurafenib, a BRAF inhibitor widely used for the clinical management of melanoma, suggesting its potential interest as dietary adjuvant increasing melanoma cells sensitivity to chemotherapy. 2
Complete list of metadatas

Cited literature [1 references]  Display  Hide  Download

https://hal.archives-ouvertes.fr/hal-01868622
Contributor : Laurent Picot <>
Submitted on : Wednesday, September 5, 2018 - 4:11:05 PM
Last modification on : Friday, April 12, 2019 - 11:18:03 AM
Long-term archiving on : Thursday, December 6, 2018 - 3:50:09 PM

Files

BJP_2018_26 - version accepté...
Files produced by the author(s)

Identifiers

Collections

Citation

Camille Juin, Raimundo Gonçalves de Oliveira Junior, Audrey Fleury, Chloé Oudinet, Lior Pytowski, et al.. Zeaxanthin from Porphyridium purpureum induces apoptosis in human melanoma cells expressing the oncogenic BRAF V600E mutation and sensitizes them to the BRAF inhibitor vemurafenib. Revista Brasileira de Farmacognosia, Elsevier, 2018, 28 (4), pp.457-467. ⟨10.1016/j.bjp.2018.05.009⟩. ⟨hal-01868622⟩

Share

Metrics

Record views

196

Files downloads

78